U.S. Stem Cell, Inc. 4
4 · U.S. Stem Cell, Inc. · Filed Feb 17, 2017
Insider Transaction Report
Form 4
U.S. Stem Cell, Inc.BHRT.OB
TOMAS MIKE
DirectorCEO & President
Transactions
- Award
Stock Option (right to buy)
2017-02-06+10,000,000→ 21,841,284 totalExercise: $0.00Exp: 2027-02-06→ Common Stock (10,000,000 underlying)
Holdings
- 9,793
Common Stock
Footnotes (1)
- [F1]2,500,000 vest on 02/06/2018, 2,500,000 vest on 02/06/2019, 2,500,000 vest on 02/06/2020, and 2,500,000 vest on 02/06/2021.